1. Home
  2. INLX vs SCLX Comparison

INLX vs SCLX Comparison

Compare INLX & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

HOLD

Current Price

$5.18

Market Cap

25.5M

Sector

Technology

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$2.82

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
SCLX
Founded
1996
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5M
27.9M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
INLX
SCLX
Price
$5.18
$2.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.4K
★ 40.3K
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$11,336.00
★ $30,253,000.00
Revenue This Year
$14.57
$118.16
Revenue Next Year
N/A
$186.31
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.12
$2.79
52 Week High
$11.10
$27.00

Technical Indicators

Market Signals
Indicator
INLX
SCLX
Relative Strength Index (RSI) 48.50 19.42
Support Level $4.12 N/A
Resistance Level $5.80 $7.77
Average True Range (ATR) 0.77 0.36
MACD -0.00 -0.10
Stochastic Oscillator 35.63 1.41

Price Performance

Historical Comparison
INLX
SCLX

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: